Day: December 1, 2021

STAT+: Amgen joins a growing list of drug makers cutting discounts to safety-net hospitals

Amid a closely watched legal battle, Amgen (AMGN) has joined the growing ranks of major drug makers curtailing the discounts offered through a federal program for safety-net hospitals and clinics. As of Jan. 3, 2022, the company will no longer offer discounts to contract pharmacies used by hospitals and clinics that serve low-income populations and […]

First case of Omicron coronavirus variant identified in the U.S.

U.S. health officials on Wednesday reported the country’s first case of the Omicron variant of the coronavirus, in a person in California who had a recent case of Covid-19. The case was identified by the California and San Francisco health departments in a person who had traveled to South Africa and returned on Nov. 22, […]

STAT+: Pharmalittle: Merck Covid pill squeaks past FDA panel; analysis explores whether insurers give ‘fair access’ to drugs

Top of the morning to you, and a fine one it is. A shiny sun and clear skies are enveloping the Pharmalot campus, where the official mascot is contentedly snoozing in a corner and street life is buzzing nearby. As for us, we are engaged in our usual ritual of brewing cups of stimulation, which […]

Opinion: Listen: Who owns your health data — and why you should care

It can be hard to fathom that anyone other than you might own your information. But they do. Everything from what’s in your electronic medical record to the average jogging speed recorded on an app may be someone else’s property. For a profit, the magic is in the aggregate. Innumerable hospitals, corporations, and apps are […]

STAT+: Socially responsible investor coalitions push greater access to medicines in shareholder proposals

Amid controversy over equitable distribution of Covid-19 vaccines, a large coalition of socially minded investor groups has filed shareholder proposals urging large drug makers to take various steps that could ultimately widen access to their medicines in the U.S. and elsewhere. The effort reflects ongoing frustration with the pharmaceutical industry over business practices that have […]

STAT+: In a medical first, Vertex drug successfully targets the underlying cause of a genetic kidney disease

An experimental pill from Vertex Pharmaceuticals reduced levels of a damaging urine protein by nearly half in a small clinical trial — encouraging evidence that a novel medicine can arrest the underlying genetic cause of a chronic kidney disease that progresses rapidly to kidney failure. Vertex called the mid-stage study results “unprecedented” and said it […]

Opinion: Stigma, not science, is the biggest barrier to ending the HIV epidemic

“I am really sorry to reach out like this, David, but I’m worried about my brother. I think he has AIDS.” I froze when I heard those words a few weeks ago. One reason was because Cheryl was 11 years old the last time I heard her voice; she’s 40 now. The other was because […]

A reason for optimism on Omicron: Our immune systems are not blank slates

The emergence of a new Covid-19 variant with a startlingly large constellation of mutations has countries around the world sounding alarms. While the concerns are understandable, experts in immunology say people need to remember a critical fact: Two years and 8 billion vaccine doses into the pandemic, many immune systems are no longer blank slates […]

Scroll to top